MARKET

JNJ

JNJ

Johnson & Johnson
NYSE
246.37
+3.88
+1.60%
Opening 10:59 02/23 EST
OPEN
243.62
PREV CLOSE
242.49
HIGH
246.56
LOW
242.60
VOLUME
2.26M
TURNOVER
--
52 WEEK HIGH
246.96
52 WEEK LOW
138.40
MARKET CAP
593.71B
P/E (TTM)
22.33
1D
5D
1M
3M
1Y
5Y
1D
Bayer Sues Johnson & Johnson, Janssen Biotech Over Alleged False Claims Regarding Efficacy Of NUBEQA
Benzinga · 27m ago
Bayer files false advertising suit against J&J and Janssen Biotech
TipRanks · 29m ago
Johnson & Johnson (JNJ) Stock Flat despite First Co-funding Agreement with Blackstone
TipRanks · 2h ago
Blackstone Life Sciences Signs Deal With JNJ To Jointly Fund Clinical Development Of Bleximenib
NASDAQ · 3h ago
Blackstone, Johnson & Johnson enter co-funding agreement for bleximenib
TipRanks · 3h ago
Blackstone Life Sciences announces a AML co-funding agreement with J&J
TipRanks · 3h ago
Weekly Report: what happened at JNJ last week (0216-0220)?
Weekly Report · 6h ago
LRGF: Low-Cost Multi-Factor ETF With Average Results
Seeking Alpha · 7h ago
More
About JNJ
Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).

Webull offers Johnson & Johnson stock information, including NYSE: JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.